| Literature DB >> 33108351 |
John T Benjamin1, Erin J Plosa1, Jennifer Ms Sucre1,2, Riet van der Meer1, Shivangi Dave1, Sergey Gutor3, David S Nichols3, Peter M Gulleman1, Christopher S Jetter1, Wei Han3, Matthew Xin3, Peter C Dinella1, Ashley Catanzarite1, Seunghyi Kook1, Kalsang Dolma4, Charitharth V Lal4, Amit Gaggar5,6,7, J Edwin Blalock5,6,7, Dawn C Newcomb3, Bradley W Richmond3,8, Jonathan A Kropski2,3,8, Lisa R Young1,2,3,9, Susan H Guttentag1, Timothy S Blackwell2,3,8.
Abstract
Emerging evidence indicates that early life events can increase the risk for developing chronic obstructive pulmonary disease (COPD). Using an inducible transgenic mouse model for NF-κB activation in the airway epithelium, we found that a brief period of inflammation during the saccular stage (P3-P5) but not alveolar stage (P10-P12) of lung development disrupted elastic fiber assembly, resulting in permanent reduction in lung function and development of a COPD-like lung phenotype that progressed through 24 months of age. Neutrophil depletion prevented disruption of elastic fiber assembly and restored normal lung development. Mechanistic studies uncovered a role for neutrophil elastase (NE) in downregulating expression of critical elastic fiber assembly components, particularly fibulin-5 and elastin. Further, purified human NE and NE-containing exosomes from tracheal aspirates of premature infants with lung inflammation downregulated elastin and fibulin-5 expression by saccular-stage mouse lung fibroblasts. Together, our studies define a critical developmental window for assembling the elastin scaffold in the distal lung, which is required to support lung structure and function throughout the lifespan. Although neutrophils play a well-recognized role in COPD development in adults, neutrophilic inflammation may also contribute to early-life predisposition to COPD.Entities:
Keywords: COPD; Extracellular matrix; Inflammation; Neutrophils; Pulmonology
Mesh:
Substances:
Year: 2021 PMID: 33108351 PMCID: PMC7773387 DOI: 10.1172/JCI139481
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808